Veeda Group has rebranded to Veeda Lifesciences, reflecting its evolution into a drug development enterprise. It comprises four strategic units: Clinical Trials, Healthy Volunteer Services, Biopharma ...
Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...
brand football Hisun Pharmaceutical's Gemcitabine Hydrochloride for Injection Passes Generic Drug Consistency Evaluation The 5 billion anti-epileptic market welcomes new blood! Eisai's Perampanel will ...